Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

05 Mar 2017 - 09 Mar 2017
20 Mar 2017 - 23 Mar 2017
12 Apr 2017 - 14 Apr 2017

Online Software Designed to Enhance Target Enrichment Custom Design Process for Next-Generation Sequencing

By BiotechDaily International staff writers
Posted on 04 Jul 2013
ADVERTISEMENT
SARTORIUS AG
A new next-generation sequencing online software’s design algorithm provides an empirically optimized probe database that allows users to obtain and review designs in an automated setting before making the purchase decision.

Roche (Basel, Switzerland) announced the worldwide launch of the NimbleDesign tool, an online software that enables customers to easily design optimized SeqCap EZ Choice Libraries in as little as one hour.

“NimbleDesign is based on years of target enrichment design experience from our bioinformatics experts,” said Thomas Schinecker, president of Roche sequencing solutions. “Following the very positive feedback we received from pilot users in selected regions we are excited to offer this software tool globally now. It marks another step in our ongoing efforts to improve the customer convenience of our target enrichment portfolio.”

The NimbleDesign application enables customers to take full use of Roche’s novel SeqCap EZ library technology, providing more effective finding of single nucleotide polymorphisms (SNPs) and better uniform coverage than many other existing technologies. Furthermore, using the easy-to-use interface, users can develop multiple designs simultaneously with very fast turnaround time. Adding to the customer convenience with the launch of SeqCap EZ reagents earlier in 2013, the NimbleDesign tool additionally streamlines the design workflow and ordering process.

The system is developed for life science research only.

Related Links:
Roche



Channels

Drug Discovery

view channel
Image: The experimental drug NGI-1 slows cancer growth by blocking glycosylation of the epidermal growth factor receptor (EGFR), which is shown in the above diagram (Photo courtesy of Wikimedia Commons).

Experimental Drug Slows Lung Cancer Growth by Blocking Protein Glycosylation

An interesting new experimental anti-cancer drug slows growth of certain lung tumor cells by preventing the glycosylation of critical cell surface receptor proteins. Asparagine (N)-linked glycosylation... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.